DGAP-News

Alzchem Group AG: Historic highs in sales and EBITDA in 9-month period 2021

DGAP-News: Alzchem Group AG / Key word(s): Quarter Results/9 Month figures Alzchem Group AG: Historic highs in sales and EBITDA in 9-month period 2021 11.11.2021 / 07:00 The issuer is solely responsible for the content of this announcement. Alzchem Group AG: Historic highs in sales and EBITDA in 9-month period 2021

Trostberg, 11 November 2021 - Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, was able to seamlessly continue the extremely positive business development of the record half-year in the 9-month period of 2021.

At EUR 311.2 million, Group sales improved by 11.7% compared with the same period of the previous year, thus reaching a new all-time high. The Specialty Chemicals segment grew by 6.7%. On the product side, DYHARD^(R) (lightweight construction, renewable energies and automotive applications) in particular shone, reinforcing the positive trend since the fourth quarter of 2020. Creapure^(R) achieved volume growth of over 40% in the reporting period. Likewise, products from the multi-purpose plants were placed in higher volumes in the specialty and fine chemicals markets. Sales of Creamino^(R) developed at the level of the previous year. At the same time, a 25% sales share with newly acquired customers demonstrates the potential for further market penetration. The Basics & Intermediates segment recorded sales growth of 20.7% in the first nine months of 2021. Demand for the building block dicyandiamide, which has major applications in the pharmaceutical industry, was strong, as was demand for almost all products of the metallurgy business unit and for Perlka^(R) products used in agriculture. The expanded production plant for the NITRALZ^(R) product range has already been commissioned and is making its contribution to further growth.

Earnings before interest, taxes, depreciation and amortization (EBITDA) also reached a new record level in the 9-month period 2021, increasing by 20.7% to EUR 49.6 million. The resulting EBITDA margin was 15.9%, compared with 14.8% in the prior-year period. The increase in material, personnel, logistics and shipping costs was more than offset by initial price increases as well as strong sales growth and the resulting rise in contribution margins. The result for the period grew by 46.0% to EUR 21.9 million in the 9-month period 2021. The equity ratio climbed from 19.4% as of December 31, 2020 to 21.3% as of September 30, 2021.